MS Treatments Aubagio TM



Similar documents
MS Treatments Gilenya

AUBAGIO Conversation Starter

Teriflunomide (Aubagio) 14mg once daily tablet

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment

Living with MS. Multiple Sclerosis Society of Canada Call toll-free in Canada: Web site:

Leflunomide Leflunomide

Intravenous Methyl Prednisolone in Multiple Sclerosis

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Gilenya. Exceptional healthcare, personally delivered

Disease Modifying Therapies for MS

Information About Medicines for Multiple Sclerosis

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

Progress in MS: Current and Emerging Therapies

Multiple sclerosis disease-modifying drugs second line treatments

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

ORAL MEDICATIONS FOR MS! Gilenya and Aubagio

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Aubagio. Aubagio (teriflunomide) Description

Disease Modifying Therapies for MS

Information about medicines for multiple sclerosis

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

Bayer Receives FDA Approval for BETACONNECT First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

Life with MS: Mastering Early Treatment

QUESTIONS TO ASK MY DOCTOR

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules

Many people with MS use some form of conventional medical treatment, and many people also use complementary and alternative medicine (CAM).

Coping with Symptoms of Multiple Sclerosis

Use of oral steroids in Multiple Sclerosis

Presenting the SUTENT Patient Call Center.

FAQs about Warfarin (brand name Coumadin )

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

Safety Information Card for Xarelto Patients

Recognizing and Understanding Pain

Tuberculosis and You A Guide to Tuberculosis Treatment and Services

Share the important information in this Medication Guide with members of your household.

Program Transcript Recorded: January 16, Brief Overview of Multiple Sclerosis

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

Learn about Diabetes. Your Guide to Diabetes: Type 1 and Type 2. You can learn how to take care of your diabetes.

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

EXTAVIA (interferon beta-1b) Do not take EXTAVIA (interferon beta-1b) if you are allergic

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

What is Multiple Sclerosis? Gener al information

Relapsing remitting MS

The Family Library. Understanding Diabetes

Genzyme s Multiple Sclerosis Franchise Featured at AAN

Health Information Sheet

Staying on Track with TUBERCULOSIS. Medicine

Managing the Symptoms of Multiple Sclerosis. Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner

CBT IN THE CITY. adjusted to the news of being with MS? April Experts at your fingertips call now. Check out our new services in you local area

Paracetamol apollo Paracetamol apollo Paracetamol

Betaferon (interferon beta 1b)

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain.

EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston

AUBAGIO (teriflunomide) oral tablet

The MS Disease- Modifying Medications GENERAL INFORMATION

Temozolomide (oral) with concurrent radiotherapy to the brain

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

Atrial Fibrillation and Anticoagulants

CHOP Chemotherapy Regimen for Lymphoma Information for Patients

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary

Treating Chronic Hepatitis C. A Review of the Research for Adults

Multiple Sclerosis (MS)

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

A Definition of Multiple Sclerosis

Lithium Therapy. Important information for patients COLLEGE CENTRE FOR QUALITY IMPROVEMENT

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

what is warfarin? Treatment with Warfarin (Coumadin ) What is warfarin?

12 Points of Tuberculosis (TB) Patient Education

Hepatitis A. What I need to know about. National Digestive Diseases Information Clearinghouse NATIONAL INSTITUTES OF HEALTH

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

National MS Society Information Sourcebook

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

St. Luke s MS Center New Patient Questionnaire. Name: Date: Birth date: Right or Left handed? Who is your Primary Doctor?

Teriflunomide (Aubagio)

CNS DEMYLINATING DISORDERS

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and

CVP Chemotherapy Regimen for Lymphoma Information for Patients

WOMENCARE A Healthy Woman is a Powerful Woman (407) Birth Control Pills

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

Multiple Myeloma Understanding your diagnosis

Living With Congestive Heart Failure

Local steroid injections

TAKING CARE OF YOUR RHEUMATOID ARTHRITIS

Transcription:

1

MSology Essentials Series Aubagio TM (teriflunomide) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Bonnie Blain Central Alberta MS Clinic, Red Deer, Alberta Peggy Cook MS Clinic, Saint John Regional Hospital, Saint John, New Brunswick Lynn McEwan London Health Sciences Centre, London, Ontario Josée Poirier MS Clinic, Hôpital Notre-Dame (CHUM), Montreal, Quebec Aubagio TM and MS One to One TM are trademarks of Genzyme, a division of sanofi-aventis

Why treat MS? Multiple sclerosis (MS) is believed to be caused by an abnormal immune response, which results in inflammation and tissue damage in the brain and spinal cord (together called the central nervous system, or CNS). This inflammation is the cause of MS symptoms, such as nerve tingling, muscle weakness, vision problems, balance difficulties and pain. New or worsening MS symptoms that last for more than a day or two are called relapses, and these generally indicate an inflammatory flare-up in the CNS. Relapse symptoms can persist for several weeks or months. Some relapses will resolve completely and some will not. As you experience more and more relapses, the body is unable to repair the damage to the brain and spinal cord, which typically leads to physical and mental impairments. That is why it is so important to treat MS to reduce inflammation and tissue damage, and reduce or delay disability. The medications prescribed are called disease-modifying therapies because they target the underlying MS disease process. They do not heal any tissue damage that has already occurred, but they may prevent further damage that will contribute to disability in the years ahead. MS medications do not treat specific symptoms, so you will not feel an improvement in the symptoms you are having. The main effects of therapy are to lessen the frequency and severity of relapses, and reduce the amount of inflammation in the brain and spinal cord. So treatment can be seen as an investment in your future lessening the often silent damage that is occurring now to prevent disabilities later on. 1

How does Aubagio work? Aubagio (teriflunomide) is an oral medication (pill) used to treat relapsing-remitting multiple sclerosis. In MS, specialized cells of the immune system become activated, enter the CNS and cause inflammation and tissue damage. Aubagio blocks the production of these overactive immune cells so there are fewer cells available to attack the body s own tissues. As a result, Aubagio modulates the abnormal immune response seen in MS, and has antiinflammatory effects in the CNS. Clinical trials of Aubagio have shown that it reduces the rate of relapses, lowers the risk of worsening disability, and suppresses inflammatory lesions in the brain in people with MS. Aubagio is a once-daily pill but you must remember to take it every day to get the full benefit of treatment. The medication will be less effective in controlling your MS if you skip doses from time to time. 2

How do I take Aubagio? Dosing Aubagio must be taken once per day. 1x a day Aubagio is a pill (14 mg) and is taken by mouth. 14 mg Aubagio may be taken with or without food. Considerations Try to get into a routine of taking it at the same time each day, such as with breakfast or with your evening meal. If you forget to take a dose, do not double up the dose. Take your pill as soon as you remember (e.g. at lunch if you forgot at breakfast) or when you would normally take the next dose (e.g. at breakfast). 14 mg 14 mg 3

How do I know my treatment is working? During your course of treatment, your doctor will monitor your response to treatment with a variety of tests and procedures. These typically include neurological examinations to evaluate your nerve and muscle function, and magnetic resonance imaging (MRI) to assess the extent of inflammatory activity in your brain and spinal cord. Other tests and procedures may also be needed during your course of treatment. What if I have a relapse? A relapse is a new MS symptom you haven t had before, or a worsening of symptoms you ve previously experienced. The symptom persists for at least 24 hours. If you become overheated from exercise, a hot bath, a fever or infection your MS can worsen for a shorter period of time, but these symptoms are not a true relapse. You may have a relapse in the first few months after starting treatment, especially if your MS was very active before. This doesn t mean your medication is not working. You will only experience the full benefit of your MS medication after you ve been taking it continuously for a few months. It s important to inform your neurologist or MS nurse if you experience a relapse or any new or worsening symptoms that last more than 24 hours. 4

What are the possible side effects of Aubagio? Hair thinning About 1 in 10 people may notice that there are extra hairs in their brush or comb. If this happens, it is most likely to occur after taking Aubagio for a few months. Hair thinning is not baldness, and the effect is generally temporary. It usually takes about six months for the natural hair cycle to replace the lost hairs. Effects on the liver Regular blood tests are needed while taking Aubagio. Tests are more frequent in the first six months after starting treatment, and less frequent thereafter. These tests are to ensure that your liver is functioning normally. Report any symptoms of liver problems to your doctor immediately. These symptoms may include unexplained nausea/vomiting, abdominal pain, dark urine, yellowing of the skin (jaundice), loss of appetite and unusual tiredness. Try to avoid consuming alcohol while taking Aubagio. All medications have the potential to cause a variety of side effects. If you experience any new, unusual or worrisome symptoms while taking your medication, report them promptly to your doctor or MS nurse. Your MS nurse can often provide helpful advice to minimize any unwanted medication-related effects you may experience. 5

Stomach upset Some people may experience stomach upset such as nausea, abdominal pain and diarrhea. It s best to take Aubagio with food if the medication upsets your stomach. These side effects usually subside after 1-2 months on treatment. Blood pressure Some people may experience a slight elevation in their blood pressure. Hair thinning Blood pressure Effects on the liver Stomach upset 6

Tests and procedures During your course of treatment, your doctor will order a number of tests to ensure that your medication is not causing any unwanted effects. Some of the suggested tests are listed in the table. However, your neurologist and MS nurse will schedule which tests you will need and how often they should be done. The tests you may need during treatment with Aubagio* Test/ procedure Blood test Reason To monitor liver function How often Before starting Aubagio Once a month or so for the first six months Periodically according to your physician The blood test will also be used to determine your complete blood cell count (CBC) Before starting Aubagio If you develop signs of an infection Blood pressure monitoring To assess blood pressure (hypertension) Before starting Aubagio Periodically according to your physician Pregnancy test (if applicable) To ensure you are not pregnant Before starting Aubagio If pregnancy is suspected during treatment Skin or blood test To ensure that you don t have tuberculosis (TB) Before starting Aubagio *Your neurologist or MS nurse will tell you more about the testing you ll need during treatment. Please ensure that you have all of the necessary tests at the recommended times. 7

Pregnancy It s generally advisable to avoid taking medications during pregnancy because they may cause harm to the developing fetus. The best approach is to talk to your doctor or MS nurse before becoming pregnant so you can work out a schedule for stopping and re-starting your medication. Aubagio should not be taken during pregnancy or breastfeeding Women and men should use a reliable method of contraception while taking Aubagio. Talk to your doctor or MS nurse if you are planning a pregnancy in the next few months. 8

Women and men must use a reliable method of contraception during treatment with Aubagio. Talk to your neurologist or MS nurse if you are planning to become pregnant soon. Simply stopping Aubagio isn t sufficient because the drug stays in the body for a long time. You will need to actively eliminate the drug from your body. This will mean taking cholestyramine or activated charcoal for 11 days. A blood test will then confirm that the drug has been removed from the body. Cholestyramine and activated charcoal affect how your body absorbs medications, including oral contraceptives, so another method of birth control should be used during the period when you are taking cholestyramine or activated charcoal. Women who become pregnant during treatment with Aubagio should stop taking the drug and contact their doctor immediately so the drug can be actively removed from the body. Aubagio should not be taken during pregnancy or breastfeeding. Aubagio may be re-started once the baby has been weaned. 9

Other medications All medications have the potential to interact with other drugs you are taking. This includes other prescription medications, as well as non-prescription drugs and alternative/complementary therapies. Some of these medications can also worsen MS symptoms. Talk to a healthcare professional before taking any new medication. Your doctor, MS nurse or pharmacist can advise you about interactions that may occur with Aubagio and the other medications you are taking. Other medical conditions Always ensure that your doctor is aware of any other medical conditions you may have. This includes high blood pressure, liver problems, diabetes, infections, or other illnesses. Resources in your community Your neurologist or MS nurse will talk to you about the MS One to One TM program, which provides information and support for people taking Aubagio. Your local pharmacist can also provide important advice on your medication, how to take it, and what other medications (including non-prescription and alternative/complementary therapies) to avoid. 10

Contacting your MS nurse Contact your MS nurse if you have any questions or concerns about your medication. It is important to notify your doctor or MS nurse if you have any new, worrisome or unusual symptoms that may be related to your medication, or any worsening of your MS symptoms. Notify your doctor or MS nurse if you have any new symptoms 11

Notes 12

The MS Essentials series provides the latest information on multiple sclerosis medications, research, and lifestyle issues such as health, nutrition and exercise. All of the booklets are developed by Lind Publishing, publishers of MSology, to help people affected by MS remain active and informed. MS Essentials is provided free of charge. The full series of publications is available for download on http://www.msology.com. The information reflects use of the medication in Canada; use may vary in other countries. MSology does not approve, endorse or recommend any specific product or therapy. Contact your healthcare providers before you start treatment, alter the dose, interrupt or discontinue your therapy. For full information about a specific medication, consult the prescribing information or package insert provided by the manufacturer for your country.

This booklet is produced by: Lind Publishing Inc. 460-376 avenue Victoria Westmount, QC H3Z 1C3 Canada Telephone: +1 (514) 482-9096 Fax: +1 (514) 482-8254 Email: Info@lindpublishing.com For more multiple sclerosis information, visit www.msology.com